NCT06572982 2026-01-14
Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients
Hikma Pharmaceuticals LLC
Phase NA Active not recruiting
Clinical Trials
8 trialsNCT05772273 2025-11-21
PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT
The First Affiliated Hospital of Soochow University
Phase NA Recruiting
NCT05471700 2025-09-23
Single Arm Study of Azacitidine and Venetoclax for Treatment of Newly Diagnosed Fit Acute Myeloid Leukemia Patients
Zhujiang Hospital
Phase NA Completed
NCT07131059 2025-08-20
MRD-positive AML Clinical Study
Institute of Hematology & Blood Diseases Hospital, China
Phase NA Recruiting
NCT06066905 2023-10-27
A Study of Chidamide With AZA in MRD Positive AML After Transplant
Guangdong Provincial People's Hospital
Phase NA Recruiting
NCT05053425 2022-04-26
Bcl-2 Inhibitors Combined With Azacytidine and Chemotherapy in Elderly Patients With Previously Untreated AML
LanZhou University
Phase NA Unknown
NCT05042531 2022-04-25
Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia
LanZhou University
Phase NA Unknown
NCT05262465 2022-03-02
Microtransplantation Combined With Azacytidine to Improve the Efficacy of EAML
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase NA Unknown